This PDF is the current document as it appeared on Public Inspection on 11/25/2016 at 08:45 am.
Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing the names of the members who will serve on its Performance Review Board (PRB). The purpose of the PRB is to provide fair and impartial review of senior executive service (SES), senior professional and Title 42 SES Equivalents performance appraisals, bonus recommendations, and pay adjustments.
Effective November 7, 2016.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Abu Sesay, Office of Human Resources Executive and Resources Management Staff, Food and Drug Administration, Three White Flint North, 05D04, 11601 Landsdown St., North Bethesda, MD 20852, 240-402-0440, firstname.lastname@example.org.End Further Info End Preamble Start Supplemental Information
This action is being taken pursuant to 5 U.S.C. 4314(c)(4), which requires that members of performance review boards be appointed in a manner to ensure consistency, stability, and objectivity in performance appraisals and requires that notice of the appointment of an individual to serve as a member be published in the Federal Register.
The following persons will serve on FDA's Performance Review Board, which oversees the evaluation of performance appraisals of FDA's senior executives: James Sigg, PRB Chair and member; Tania Tse, PRB Officiator; Glenda Barfell; Vincent Bunning; Mary Beth Clarke; Tracey Forfa; Leslie Kux; Deanna Murphy; Lynne Rice; and Richard Turman.Start Signature
Dated: November 21, 2016.
Associate Commissioner for Policy.
[FR Doc. 2016-28452 Filed 11-25-16; 8:45 am]
BILLING CODE 4164-01-P